NF-κB and Apoptosis in Mammary Epithelial Cells

Journal of Mammary Gland Biology and Neoplasia

Volumn 4, Issue 2, 1999, Pages 165-175

  Clarkson, Richard W E ^a   Watson, Christine J ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Apoptosis; Epithelia; Mammary gland; NF B

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TRANSCRIPTION FACTOR;

ANIMAL; APOPTOSIS; CYTOLOGY; EPITHELIUM CELL; EXPERIMENTAL NEOPLASM; FEMALE; GENE EXPRESSION REGULATION; GENETICS; GROWTH, DEVELOPMENT AND AGING; METABOLISM; MORPHOGENESIS; MOUSE; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; UDDER;

ANIMALS; APOPTOSIS; EPITHELIAL CELLS; FEMALE; GENE EXPRESSION REGULATION; MAMMARY GLANDS, ANIMAL; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MORPHOGENESIS; NF-KAPPA B; TRANSCRIPTION FACTORS;

EID: 0033109033     PISSN: 10833021     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1018725207969     Document Type: Article

References (76)

1. G. W. Robinson, P. F. Johnson, L. Hennighausen, E. Sterneck (1998). The c/ebp beta transcription factor regulates epithelial cell proliferation and differentiation in the mammary gland. Genes Dev. 12:1907-1916.
2. X. W. Liu, G. W. Robinson, K. U. Wagner, L. Garrett, A. Wynshaw-Boris, L. Hennighausen (1997). Stat5a is mandatory for adult mammary gland development and lactogenesis. Genes Dev. 11:179-186.
3. T. N. Seagroves, S. Krnacik, B. Raught, J. Gay, B. Burgess-Beusse, G. J. Darlington, J. M. Rosen (1998). C/ebp beta, but not c/ebp alpha, is essential for ductal morphogenesis, lobuloalveolar proliferation, and functional differentiation in the mouse mammary gland. Genes Dev. 12:1917-1928.
4. A. Fraser and G. Evan (1996). A license to kill. Cell 85: 781-784.
5. E. Bossy-Wetzel, L. Bakiri, and M. Yaniv (1997). Induction of apoptosis by the transcription factor c-jun. EMBO J. 16:1695-1709.
6. H. Steller (1995). Mechanisms and genes of cellular suicide. Science 267:1445-1449.
7. L. J. Miller and J. Marx (1998). Apoptosis: Special review series. Science 281:1301
8. R. Sen and D. Baltimore (1986). Multiple nuclear factors interact with the immunoglobulin enhancer sequences. Cell 46: 705-716.
9. T. Collins (1993). Biology of disease - endothelial nuclear factor-kappa-b and the initiation of the atherosclerotic lesion. Lab. Invest. 68:499-508.
10. S. Ghosh, M. J. May, and E. B. Kopp (1998). NF-kappa B and Rel proteins: Evolutionarily conserved mediators of immune responses. Ann. Rev. Immunol. 16:225-260.
11. M. Karin (1998). The NF-kappa B activation pathway: Its regulation and role in inflammation and cell survival. Cancer J. Sci. Amer. 4:S92-S99.
12. S. Gerondakis, R. Grumont, I. Rourke, M. Grossmann (1998). The regulation and roles of Rel/NF-kappa B transcription factors during lymphocyte activation. Current Opin. Immunol. 10:353-359.
13. M. J. May and S. Ghosh (1998). Signal transduction through NF-kappa B. Immunol. Today 19:80-88.
14. C. Kunsch, S. M. Ruben, and C. A. Rosen (1992). Selection of optimal kappa-B/Rel DNA-binding motifs-interaction of both subunits of NF-kappa-B with DNA is required for transcriptional activation. Mol. Cell. Biol. 12:4412-4421.
15. V. Imbert, R. A. Rupec, A. Livolsi, H. L. Pahl, E. B. M. Traenckner, C. MuellerDieckmann, D. Farahifar, B. Rossi, P. Auberger, P. A. Baeuerle, J.-F. Peyron (1996). Tyrosine phosphorylation of I kappa B-alpha activates NF-kappa B without proteolytic degradation of I kappa B-alpha. Cell 86:787-798.
16. M. Naumann and C. Scheidereit (1994). Activation of NF-kappa-B in vivo is regulated by multiple phosphorylations. EMBO J. 13:4597-4607.
17. H. H. Zhong, H. Su Yang, H. Erdjument-Bromage, P. Tempst, and S. Ghosh (1997). The transcriptional activity of nf-kappa b is regulated by the I kappa B-associated PKAC subunit through a cyclic AMP-independent mechanism. Cell 89:413-424.
18. B. Stein, P. C. Cogswell, and A. S. Baldwin (1993). Functional and physical associations between NF-kappa-B and c/ebp family members - a Rel domain-bZIP interaction. Mol. Cell. Biol. 13:3964-3974.
19. B. Stein and A. S. Baldwin (1993). Distinct mechanisms for regulation of the interleukin-8 gene involve synergism and cooperativity between c/ebp and NF-kappa-B. Mol. Cell. Biol. 13:7191-7198.
20. R. I. Scheinman, A. Gualberto, C. M. Jewell, J. A. Cidlowski, and A. S. Baldwin (1995). Characterization of mechanisms involved in transrepression of NF-kappa-B by activated glucocorticoid receptors. Mol. Cell. Biol. 15:943-953.
21. A. A. Beg, W. C. Sha, R. T. Bronson, S. Ghosh, and D. Baltimore (1995). Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-kappa-B. Nature 376:167-170.
22. W. C. Sha, H. C. Liou, E. I. Tuomanen, and D. Baltimore (1995). Targeted disruption of the p50 subunit of NF-kappa-B leads to multifocal defects in immune-responses. Cell 80: 321-330.
23. F. Weih, D. Carrasco, S. K. Durham, D. S. Barton, C. A. Rizzo, R. P. Ryseck, S. A. Lira, and R. Bravo (1995). Multiorgan inflammation and hematopoietic abnormalities in mice with a targeted disruption of RelB, a member of the NF-kappa-B/Rel family. Cell 80:331-340.
24. C. Abbadie, N. Kabrun, F. Bouali, J. Smardova, D. Stehelin, B. Vandenbunder, and P. J. Enrietto (1993). High-levels of c-Rel expression are associated with programmed cell-death in the developing avian embryo and in bone-marrow cells in vitro. Cell 75:899-912.
25. P. A. Baeuerle and D. Baltimore (1996) NF-kappa B: Ten years after. Cell 87:13-20.
26. D. J. VanAntwerp, S. J. Martin, I. M. Verma, and D. R. Green (1998). Inhibition of TNF-induced apoptosis by NF-kappa B. Trends Cell Biol. 8:107-111.
27. S. Grimm, M. K. A. Bauer, P. A. Baeuerle, and K. Schulze-Osthoff (1996). Bcl-2 down-regulates the activity of transcription factor NF-kappa B induced upon apoptosis. J. Cell Biol. 134:13-23.
28. D. J. VanAntwerp, S. J. Martin, T. Kafri, D. R. Green, and I. M. Verma (1996). Suppression of TNF-alpha-induced apoptosis by NF-kappa B. Science 274:787-789.
29. C. Y. Wang, M. W. Mayo, and A. S. Baldwin (1996). TNF- and career therapy-induced apoptosis: Potentiation by inhibition of NF-kappa-B. Science 274:784-787.
30. K. Brown, S. Gerstberger, L. Carlson, G. Franzoso, and U. Siebenlist (1995). Control of I-kappa-B-alpha proteolysis by site-specific, signal-induced phosphorylation. Science 267: 1485-1488.
31. A. A. Beg and D. Baltimore (1996). An essential role for NF-kappa B in preventing tnf-alpha-induced cell death. Science 274:782-784.
32. D. Wallach (1997). Cell death induction by TNF: A matter of self control. Trends Biochem. Sci. 22:107-109.
33. C. Y. Wang, M. W. Mayo, R. G. Korneluk, D. V. Goeddel, and A. S. Baldwin (1998). NF-kappa B antiapoptosis: Induction of TRAF1 and TRAF2 and c-IAP1 and C-IAP2 to suppress cas-pase-8 activation. Science 281:1680-1683.
34. M. Wu, M. Arsura, R. E. Bellas, M. J. Fitzgerald, H. Y. Lee, S. L. Schauer, D. H. Sherr, and G. E. Sonenshein (1996). Inhibition of c-myc expression induces apoptosis of WEHI 231 murine B cells. Mol. Cell. Biol. 16:5015-5025.
35. H. Y. Wu and G. Lozano (1994). NF-kappa-B activation of p53 - a potential mechanism for suppressing cell-growth in response to stress. J. Biol. Chem. 269:20067-20074.
36. R. Strange, F. Li, S. Saurer, A. Burkhardt, and R. R. Friis (1992). Apoptotic cell-death and tissue remodeling during mouse mammary-gland involution. Development 115:49-58.
37. G. R. Merlo, F. Basolo, L. Fiore, L. Duboc, and N. E. Hynes (1995). P53-dependent and p53-independent activation of apoptosis in mammary epithelial-cells reveals a survival function of EGF and insulin. J. Cell Biol. 128:1185-1196.
38. N. Boudreau, Z. Werb, and M. J. Bissell (1996). Suppression of apoptosis by basement membrane requires three-dimensional tissue organization and withdrawal from the cell cycle. Proc. Natl. Acad. Sci. U.S.A. 93:3509-3513.
39. D. Carrasco, F. Weih, and R. Bravo (1994). Developmental expression of the mouse c-Rel protooncogene in hematopoietic organs. Development 120:2991-3004.
40. R. Schmidt-Ullrich, S. Memet, A. Lilienbaum, J. Feuillard, M. Raphael, and A. Israel (1996). NF-kappa B activity in transgenic mice: Developmental regulation and tissue specificity. Development 122:2117-2128.
41. P. B. Bushdid, D. M. Brantley, F. E. Yull, G. L. Blaeuer, L. H. Hoffman, and L. Niswander, L. D. Kerr (1998). Inhibition of NF-kappa B activity results in disruption of the apical ectodermal ridge and aberrant limb morphogenesis. Nature 392:615-618.
42. Y. Kanegae, A. T. Tavares, J. C. I. Belmonte, and I. M. Verma (1998). Role of Rel/NF-kappa B transcription factors during the outgrowth of the vertebrate limb. Nature 392:611-614.
43. C. S. Seitz, Q. Lin, H. Deng, and P. A. Khavari (1998). Alterations in NF-kappa B function in transgenic epithelial tissue demonstrate a growth inhibitory role for NF-kappa B. Proc. Natl. Acad. Sci. U.S.A. 95:2307-2312.
44. M. A. Sovak, R. E. Bellas, D. W. Kim, G. J. Zanieski, A. E. Rogers, A.M. Traish, and G.E. Sonenshein (1997). Aberrant nuclear factor-kappa B/Rel expression and the pathogenesis of breast cancer. J. Clin. Invest. 100:2952-2960.
45. B. Stein, A. S. Baldwin, D. W. Ballard, W. C. Greene, P. Angel, and P. Herrlich (1993). Cross-coupling of the NF-beta-B p65 and fos jun transcription factors produces potentiated biological function. EMBO J. 12:3879-3891.
46. E. Dejardin, G. Bonizzi, A. Bellahcene, V. Castronovo, M. P. Merville, and V. Bours (1995). Highly-expressed p100/p52 (nfkb2) sequesters other NF-kappa-B-related proteins in the cytoplasm of human breast-cancer cells. Oncogene 11:1835-1841.
47. H. Nakshatri, P. Bhat-Nakshatri, D. A. Martin, R. J. Goulet, and G. W. Sledge (1997). Constitutive activation of NF-kappa B during progression of breast cancer to hormone-independent growth. Mol. Cell. Biol. 17:3629-3639.
48. D. Adam, U. Kessler, and M. Kronke (1995). Cross-linking of the p55 tumor-necrosis-factor receptor cytoplasmic domain by a dimeric ligand induces nuclear factor-kappa-B and mediates cell-death. J. Biol. Chem. 270:17482-17487.
49. Z. Z. Cai, M. Korner, N. Tarantino, and S. Chouaib (1997). I kappa B alpha overexpression in human breast carcinoma mcf7 cells inhibits nuclear factor-kappa B activation but not tumor necrosis factor-alpha-induced apoptosis. J. Biol. Chem. 272: 96-101.
50. M. C. Raff (1992). Social controls on cell-survival and cell-death. Nature 356:397-400.
51. M. L. Li, X. W. Liu, G. Robinson, U. Bar-Peled, K. U. Wagner, W. S. Young, L. Hennighausen, and P. A. Furth (1997). Mammary-derived signals activate programmed cell death during the first stage of mammary gland involution. Proc. Natl. Acad. Sci. U.S.A. 94:3425-3430.
52. K. Hishikawa, B. S. Oemar, Z. H. Yang, and T. F. Luscher (1997). Pulsatile stretch stimulates superoxide production and activates nuclear factor-kappa B in human coronary smooth muscle. Circulation Res. 81:797-803.
53. M. Scatena, M. Almeida, M. L. Chaisson, N. Fausto, R. F. Nicosia, and C. M. Giachelli (1998). NF-kappa B mediates alpha v beta 3 integrin-induced endothelial cell survival. J. Cell Biol. 141:1083-1093.
54. D. Ramarli, M. T. Scupoli, E. Fiorini, O. Poffe, M. Brentegani, A. Villa, G. Cecchini, G. Tridente, and P. C. Marchisio (1998). Thymocyte contact or monoclonal antibody-mediated clustering of alpha 3 beta 1 or alpha 6 beta 4 integrins activate interleukin-6 (IL-6) transcription factors (NF-kappa B and NF-IL6) and IL-6 production in human thymic epithelial cells. Blood 92:3745-3755.
55. J. H. Xu, M. M. Zutter, S. A. Santoro, and R. A. F. Clark (1998). A three-dimensional collagen lattice activates NF-kappa B in human fibroblasts: Role in integrin alpha(2) gene expression and tissue remodeling. J. Cell Biol. 140:709-719.
56. A. Bearz, G. Tell, A. Colombatti, S. Formisano, and C. Pucillo (1998). Fibronectin binding promotes a PKC-dependent modulation of NF-kappa B in human T cells. Biochem. Biophys. Res. Commun. 243:732-737.
57. J. D. Li, W. J. Feng, M. Gallup, J. H. Kim, J. Gum, Y. Kim, and C. Basbaum (1998). Activation of NF-kappa B via a src-dependent ras-mapk-pp90rs k pathway is required for pseudomonas aeruginosa-induced mucin overproduction in epithelial cells. Proc. Natl. Acad. Sci. U.S.A. 95:5718-5723.
58. D. M. Eicher, T. H. Tan, N. R. Rice, J. J. Oshea, and I. C. S. Kennedy (1994). Expression of v-src in T-cells correlates with nuclear expression of NF-kappa-B. J. Immunol. 152:2710-2719.
59. A. K. Andersson and S. Sandler (1998). Involvement of PI-3 kinase in IL-1 beta induced activation of NF kappa B in beta-cells. Diabetologia 41:606
60. A. P. Soler, C. W. Marano, M. Bryans, R. D. Miller, L. A. Garulacan, S. K. Mauldin, V. Poltoratsky, T. D. Stamato, and I. M. Mullin (1997). Curcumin alters the barrier function of an epithelium undergoing TNF-induced apoptosis by inhibiting PI-3 kinase and NF-kappa B activation. FASEB J. 11:2987.
61. R. Narayanan, K. A. Higgins, J. R. Perez, T. A. Coleman, and C. A. Rosen (1993). Evidence for differential functions of the p50 and p65 subunits of NF-kappa-B with a cell-adhesion model. Mol. Cell. Biol. 13:3802-3810.
62. R. Perona, S. Montaner, L. Saniger, I. SanchezPerez, R. Bravo, and J. C. Lacal (1997). Activation of the nuclear factor-kappa B by rho, cdc42, and rac-1 proteins. Genes Dev. 11:463-475.
63. M. Spiecker, H. B. Peng, and J. K. Liao (1997). Inhibition of endothelial vascular cell adhesion molecule-1 expression by nitric oxide involves the induction and nuclear translocation of I kappa B alpha. J. Biol. Chem. 272:30969-30974.
64. L. Cominacini, U. Garbin, A. F. Pasini, T. Paulon, A. Davoli, M. Campagnola, E. Marchi, A. M. Pastorino, G. Gaviraghi, and V. LoCascio (1997). Lacidipine inhibits the activation of the transcription factor NF-kappa B and the expression of adhesion molecules induced by pro- oxidant signals on endothelial cells. J. Hypertension 15:1633-1640.
65. J. H. Chen, C. Vercamer, Z. L. Li, D. Paulin, B. Vandenbunder, and D. Stehelin (1996). Pea3 transactivates vimentin promoter in mammary epithelial and tumor cells. Oncogene 13: 1667-1675.
66. C. Jobin, C. Hellerbrand, L. L. Licato, D. A. Brenner, and R. B. Sartor (1998). Mediation by NF-kappa B of cytokine induced expression of intercellular adhesion molecule 1 (ICAM-1) in an intestinal epithelial cell line, a process blocked by proteasome inhibitors. Gut 42:779-787.
67. I. Kurose, H. Saito, S. Miura, H. Ebinuma, H. Higuchi, N. Watanabe, S. Zeki, T. Nakamura, M. Takaishi, and H. Ishii (1997). Cd18/icam-1-dependent oxidative NF-kappa B activation leading to nitric oxide production in rat kupffer cells cocultured with syngeneic hepatoma cells. J. Clin. Invest. 99: 867-878.
68. A. S. Gukoyskaya, I. Y. Gukovsky, S. Periskic, T. Blinman, V. Zaninovich, and S. J. Pandol (1997). Loss of extracellular matrix contacts leads to NF-kb activation, cytokine expression, and production and apoptosis in pancreatic acinar cell. Gastroenterology 112:A446.
69. C. H. Yang, A. Murti, and L. M. Pfeffer (1998). Stat3 complements defects in an interferon-resistant cell line: Evidence for an essential role for Stat3 in interferon signaling and biological activities. Proc. Natl. Acad. Sci. U.S.A. 95:5568-5572.
70. V. A. Fadok, D. R. Voelker, P. A. Campbell, J. J. Cohen, D. L. Bratton, and P. M. Henson (1992). Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J. Immunol. 148:2207-2216.
71. N. Boudreau, C. J. Sympson, Z. Werb, and M. J. Bissell (1995). Suppression of ice and apoptosis in mammary epithelial-cells by extracellular-matrix. Science 267:891-893.
72. M. M. Faraldo, M. A. Deugnier, M. Lukashev, J. P. Thiery, and M. A. Glukhova (1998). Perturbation of beta 1-integrin function alters the development of murine mammary gland. EMBO J. 17:2139-2147.
73. R. E. Ellis, J. Y. Yuan, and H. R. Horvitz (1991). Mechanisms and functions of cell-death. Ann. Rev. Cell Biol. 7:663-698.
74. J. A. C. Philp, T. G. Burdon, and C. J. Watson (1996). Differential activation of Stats 3 and 5 during mammary gland development. FEBS Lett. 396:77-80.
75. K. U. Wagner, R. J. Wall, L. St. Onge, P. Gruss, A. Wynshaw-Boris, L. Garrett, M. L. Li, P. A. Furth, and L. Hennighausen (1997). Cre-mediated gene deletion in the mammary gland. Nucleic Acids Res. 25:4323-4330.
76. S. Selbert, D. J. Bentley, D. W. Melton, D. Rannie, P. Lourenco, C. J. Watson, and A. R. Clarke (1998). Efficient blg-cre mediated gene deletion in the mammary gland. Transgenic Res. 7:387-396.